Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT06466005 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

UnityPhilly Response App for Overdose Reversal

StatusRecruiting
PhaseNot applicable
Started
View on ClinicalTrials.gov ↗

Record History

See every version on ClinicalTrials.gov ↗

  1. Phase changed: not specified → not applicablev5
  2. Trial status: Not Yet Recruiting to Recruitingv4 Show 4 more changesShow less
    • Primary completion date: Dec 2026 to Dec 2027
    • Start date changed from estimate of Aug 1, 2025 to Sep 16, 2025
    • Site details revised
    • Collaborators: 2 to 1
  3. Start date: Nov 1, 2024 to Aug 1, 2025
    • Trial status: Enrolling by Invitation to Not Yet Recruiting
    • Primary completion date: Sep 2026 to Dec 2026
    v3
  4. Trial status: Not Yet Recruiting to Enrolling by Invitation
    • Study sites: 0 to 1
    • Start date changed from estimate of Oct 2024 to Nov 1, 2024
    v2
  5. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
The goal of this clinical trial is to discover if an overdose prevention app (UnityPhilly) can encourage citizen responders to respond and prevent opioid overdoses using the UnityPhilly app. The main hypotheses to answer are: Hypothesis 1: UnityPhilly signal rates relative to EMS calls will increase over time. The primary outcome will be assessed as the total number of overdoses signaled by participants relative to all overdose-related EMS calls, per year. Hypothesis 2: The number of cases where a nearby UnityPhilly participant successfully reverses an overdose with naloxone will increase over time. The primary outcome will be assessed as the number of successful reversals relative to the total number of responder arrivals, per year. Participants will be supplied with the UnityPhilly app, training on how to use the app and respond to an opioid overdose using naloxone, and respond to follow up surveys about their experiences.
Trial Details
NCT Number NCT06466005
Lead Sponsor Drexel University
Collaborators: University of Michigan
Conditions
(from sponsor)		 Opioid Overdose
Related terms Opiate Overdose
Enrollment 450 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov